Metabolomics and Personalized Medicine

Advances in Protein Chemistry and Structural Biology

Volumn 102, Issue , 2016, Pages 53-78

  Koen, Nadia ^a   Du Preez, Ilse ^a   Loots, Du Toit ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Diagnostics; Metabolomics; Personalized medicine; Toxicity; Treatment

Indexed keywords

BIOLOGICAL MARKER;

ANALYTIC METHOD; CONFERENCE PAPER; DRUG MECHANISM; DRUG TOXICITY; GENOMICS; HUMAN; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; NONHUMAN; PERSONALIZED MEDICINE; PHARMACOKINETICS; PHARMACOMETABONOMICS; PRIORITY JOURNAL; PROTEOMICS; SIZE EXCLUSION CHROMATOGRAPHY; STATISTICAL ANALYSIS; TRANSCRIPTOMICS; TREATMENT RESPONSE; PHARMACOGENETICS; PROCEDURES; STATISTICS AND NUMERICAL DATA;

BIOMARKERS; HUMANS; METABOLOMICS; PHARMACOGENETICS; PRECISION MEDICINE;

EID: 84951336211     PISSN: 18761623     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.apcsb.2015.09.003     Document Type: Conference Paper

References (70)

1. C. Antunes, J. Han, R. Ferreira, P. Lolic, C. Borchers, and B.B. Finlay Effect of antibiotic treatment on the intestinal metabolome Antimicrobial Agents and Chemotherapy 55 4 2011 1494 1503
2. E. Baraldi, S. Carraro, G. Giordano, F. Reniero, G. Perilongoand, and F. Zacchello Metabolomics: Moving towards personalized medicine Italian Journal of Pediatrics 35 30 2009 12 16
3. R. Beger, J. Sun, and L. Schnackenberg Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity Toxicology and Applied Pharmacology 243 2010 154 166
4. M. Bogdanov, W. Matson, L. Wang, T. Matson, R. Saunders-Pullman, S. Bressman, and et al. Metabolomic profiling to develop blood biomarkers for Parkinson's disease Brain 131 2008 389 396
5. C. Bonhommea, C. Gervaisa, and D. Laurencin Recent NMR developments applied to organic-inorganic materials Progress in Nuclear Magnetic Resonance Spectroscopy 77 2014 1 48
6. C. Broeckling, I. Reddy, A. Duran, X. Zhao, and L. Sumner MET-IDEA: Data extraction tool for mass spectrometry-based metabolomics Analytical Chemistry 78 2006 4334 4341
7. S. Carraro, B. Andreola, R. Alinovi, M. Corradi, L. Freo, and L. Da Dalt Exhaled leukotriene B4 in children with community acquired pneumonia Pediatric Pulmonology 43 2008 982 986
8. C. Chen, F. Gonzalez, and J.R. Idle LC-MS-based metabolomics in drug metabolism Informa Healthcare 39 2007 581 597
9. A. Clayton, D. Baker, J. Lindon, J. Everett, and J. Nicholson Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism PNAS 106 34 2009 14728 14733
10. M.K. Das, S. Bishwal, A. Das, D. Dabral, V. Badireddy, B. Pandit, and et al. Deregulated tyrosine - phenylalanine metabolism in pulmonary tuberculosis patients Journal of Proteome Research 14 2015 1947 1956
11. L.P. de Carvalho, C. Darby, K. Rhee, and C. Nathan Nitazoxanide disrupts membrane potential and intrabacterial ph homeostasis of mycobacterium tuberculosis ACS Medicinal Chemistry Letters 2 2011 849 854
12. L. de Villiers, and D.T. Loots Using metabolomics for elucidating the mechanisms related to tuberculosis treatment failure Current Metabolomics 1 4 2013 306 317
13. H. Debas, R. Laxminarayan, and S. Straus Complementary and alternative medicine D. Jamison, Disease control priorities in developing countries 2nd ed. 2006 World Bank Washington, DC, USA http://www.ncbi.nlm.nih.gov/books/NBK11796/
14. J. Denery, A. Nunes, M. Hixon, T. Dickerson, and K. Janda Metabolomics-based discovery of diagnostic biomarkers for onchocerciasis PLoS Neglected Tropical Diseases 4 10 2010 10.1371/journal.pntd.0000834
15. M. Deng, H. Eisen, and M. Mehra Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling American Journal of Transplantation 6 2006 150 160
16. I. Du Preez, and D.T. Loots Altered fatty acid metabolism due to rifampicin-resistance conferring mutations in the rpoB gene of mycobacterium tuberculosis: Mapping the potential of pharmaco-metabolomics for global health and personalized medicine A Journal of Integrative Biology 16 11 2012 596 603
17. W. Dunn, N. Bailey, and H. Johnson Measuring the metabolome: Current analytical technologies Analyst 130 2005 606 625
18. R. Dworkina, M. McDermottb, J. Farrarc, A. O'Connord, and S. Senn Interpreting patient treatment response in analgesic clinical trials: Implications for genotyping, phenotyping, and personalized pain treatment PAIN 155 2014 457 460
19. T. Ebbels, H. Keun, O. Beckonert, M. Bollard, J. Lindon, E. Holmes, and et al. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: The consortium on metabonomic toxicology screening approach Journal of Proteome Research 6 2007 4407 4422
20. S. Garrod, M. Bollard, A. Nicholls, S. Connor, J. Connelly, J. Nicholson, and et al. Integrated metabonomic analysis of the multiorgan effects of hydrazine toxicity in the rat Chemical Research in Toxicology 18 18 2005 115 122
21. G.S. Ginsburg, and H.F. Willard Genomic and personalized medicine: Foundations and applications Translational Research 154 2009 277 287
22. J.M. Halket, D. Waterman, A.M. Przyborowska, R.K. Patel, P.D. Fraser, and P.M. Bramley Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS Journal of Experimental Botany 56 2005 219 243
23. S. Halouska, O. Chacon, R. Fenton, D. Zinniel, R. Barletta, and R. Powers Use of NMR metabolomics to analyze the targets of D-cycloserine in mycobacteria: Role of D-alanine racemase Journal of Proteome Research 6 2007 4608 4614
24. B. Heidecker, E. Kasper, I. Wittstein, H. Champion, E. Breton, S. Russell, and et al. Transcriptomic biomarkers for individual risk assessment in new-onset heart failure Circulation 118 2008 238 246
25. L. Hernandez, and D. Blazer Genetics and Health Institute of Medicine (US) Committee on Assessing Interactions Among Social, Genes, Behavior, and the Social Environment Moving beyond the nature/nurture debate 2006 National Academies Press (US) Washington, DC http://www.ncbi.nlm.nih.gov/books/NBK19932/
26. E. Holmes, F. Bonner, B. Sweatman, J. Lindon, C. Beddell, E. Rahr, and et al. Nuclear magnetic resonance spectroscopy and pattern recognition analysis of the biochemical processes associated with the progression of and recovery from nephrotoxic lesions in the rat induced by mercury(II) chloride and 2-bromoethanamine Molecular Pharmacology 42 1992 922 930
27. H. Hong, W. Zhang, Z. Su, J. Shen, W. Ge, B. Ning, and et al. Next-generation sequencing (NGS): A revolutionary technology in pharmacogenomics and personalized medicine Omics for personalized medicine 2013 Springer India 39 61
28. K.K. Jain Textbook of personalized medicine 2009 Springer Science + Business Media New York, NY
29. Y. Ji, S. Hebbring, H. Zhu, G. Jenkins, J. Biernacka, K. Snyder, and et al. Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: Pharmacometabolomics-informed pharmacogenomics Clinical Pharmacology & Therapeutics 89 1 2011 97 104
30. R.L. Jirtle, and M.K. Skinner Environmental epigenomics and disease susceptibility Nature Reviews 8 2007 253 262
31. C. Johnson, A. Patterson, J. Idle, and F. Gonzalez Xenobiotic metabolomics: Major impact on the metabolome Annual Review of Pharmacology and Toxicology 52 2012 37 56
32. H.C. Keun Metabonomic modeling of drug toxicity Pharmacology & Therapeutics 109 2006 92 106
33. C. Knox, V. Law, T. Jewison, P. Liu, S. Ly, A. Frolkis, and et al. DrugBank 3.0: A comprehensive resource for 'Omics' research on drugs Nucleic Acids Research 39 2011 D1035 D1041
34. K. Lan, and W. Jia An integrated metabolomics and pharmacokinetics strategy for multi-component drugs evaluation Current Drug Metabolism 11 1 2010 105 114
35. K. Lawton, A. Berger, M. Mitchell, E. Milgram, A. Evans, L. Guo, and et al. Analysis of the adult human plasma metabolome Future Medicine 9 4 2008 383 397
36. M.G. Lecea, and M. Rossbach Translational genomics in personalized medicine-scientific challenges en route to clinical practice The HUGO Journal 6 2 2012 1 9
37. E. Lenz, J. Nicholson, I. Wilson, and J. Timbrell A 1H NMR spectroscopic study of the biochemical effects of ifosfamide in the rat: Evaluation of potential biomarkers Biomarkers 5 2000 424 435
38. J. Lindon, H. Keun, T. Ebbels, J. Pearce, E. Holmes, and J. Nicholson The consortium for metabonomic toxicology (COMET): Aims, activities and achievements Pharmacogenomics 6 2005 691 699
39. J. Lindon, J. Nicholson, E. Holmes, H. Antti, M. Bollard, H. Keun, and et al. Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project Toxicology and Applied Pharmacology 187 2003 137 146
40. D.T. Loots An altered mycobacterium tuberculosis metabolome induced by katG mutations resulting in isoniazid resistance Antimicrobial Agents and Chemotherapy 58 4 2014 2144 2149 10.1128/AAC.02344-13
41. D.T. Loots, I.J. Wiid, B.J. Page, L.J. Mienie, and P.D. Helden Melatonin prevents the free radical and MADD metabolic profiles induced by antituberculosis drugs in an animal model Journal of Pineal Research 38 2 2005 100 106
42. C. Lu, J. Deng, L. Li, D. Wang, and G. Li Application of metabolomics on diagnosis and treatment of patients with psoriasis in traditional Chinese medicine Biochimica et Biophysica Acta 1844 2014 280 288
43. R. Madsen, T. Lundstedt, and J. Trygg Chemometrics in metabolomics - A review in human disease diagnosis Analytica Chimica Acta 659 2010 23 33
44. P. Marriott, and R. Shellie Principles and applications of comprehensive two-dimensional gas chromatography Trends in Analytical Chemistry 21 2002 573 583
45. H. Matthews Racial, ethnic and gender differences in response to medicines Drug Metabolism and Personalized Therapy 12 2 1995 77 92
46. S. Nishiumi, T. Kobayashi, A. Ikeda, T. Yoshie, M. Kibi, Y. Izumi, and et al. A novel serum metabolomics-based diagnostic approach for colorectal cancer PLoS One 7 7 2012 10.1371/journal.pone.0040459
47. I. Olivier, and D. Loots A metabolomics approach to characterise and identify various Mycobacterium species Journal of Microbiological Methods 88 3 2012 419 426
48. M. Ono, M. Shitashige, K. Honda, T. Isobe, H. Kuwabara, H. Matsuzuki, and et al. Label-free quantitative proteomics using large peptide data sets generated by nanoflow liquid chromatography and mass spectrometry Molecular & Cellular Proteomics 5 2006 1338 1347
49. K. Redekop, and D. Mladsi The faces of personalized medicine: A framework for understanding its meaning and scope Value in Health 16 2013 S4 S9
50. D. Robertson, M. Reily, R. Sigler, D. Wells, D. Paterson, and T. Braden Metabonomics: Evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants Toxicological Sciences 57 2000 326 337
51. S. Rozen, M. Cudkowicz, M. Bogdanov, W. Matson, B. Kristal, C. Beecher, and et al. Metabolomic analysis and signatures in motor neuron disease Metabolomics 1 2 2005 101 108
52. K. Salari The dawning era of personalized medicine exposes a gap in medical education PLoS Medicine 6 8 2009 1 3
53. L. Schnackenberg, Y. Dragan, M. Reily, D. Robertson, and R. Beger Evaluation of NMR spectral data of urine in conjunction with measured clinical chemistry and histopathology parameters to assess the effects of liver and kidney toxicants Metabolomics 2 2007 87 100
54. G. Schwartz, K. Hughes, and H. Lynch Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management Cancer 113 2008 2627 2637
55. M. Sugimoto, D. Wong, A. Hirayama, T. Soga, and M. Tomita Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles Metabolomics 6 2010 78 95
56. S. Sumner, J. Burgess, R. Snyder, J. Popp, and T. Fennell Metabolomics of urine for the assessment of microvesicular lipid accumulation in the liver following isoniazid exposure Metabolomics 6 2010 238 249
57. E. Szymanska, J. Bouwman, K. Strassburg, J. Vervoort, A. Kangas, P. Soininen, and et al. Gender-dependent associations of metabolite profiles and body fat distribution in a healthy population with central obesity: Towards metabolomics diagnostics OMICS A Journal of Integrative Biology 16 12 2012 652 667
58. S. Tiziani, A. Lodi, F. Khanim, M. Viant, C. Bunce, and U. Günther Metabolomic profiling of drug responses in acute myeloid leukaemia cell lines PLoS One 4 4 2009 10.1371/annotation/39584d38-04f5-4b37-bfd8-eae2318ec6f9
59. M. Trupp, H. Zhu, W. Wikoff, R. Baillie, Z.-B. Zeng, P. Karp, and et al. Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment PLoS One 7 7 2012 10.1371/journal.pone.0038386
60. J. Trygg, E. Holmes, and T. Lundstedt Chemometrics in metabonomics Journal of Proteome Research 6 2007 469 479
61. M. Urban, D. Kavvadiasa, K. Riedela, G. Scherera, and A. Trickerb Urinary mercapturic acids and a hemoglobin adduct for the dosimetry of acrylamide exposure in smokers and nonsmokers Inhalation Toxicology: International Forum for Respiratory Research 18 10 2006 831 839
62. D. Voora, H. McLeod, C. Eby, and B. Gage The pharmacogenetics of coumarin therapy Pharmacogenomics 6 2005 503 513
63. X. Wang, A. Zhang, P. Wang, H. Sun, G. Wu, W. Sun, and et al. Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies Molecular & Cellular Proteomics 12 2013 1226 1238
64. S. Wei, L. Liub, J. Zhang, J. Bowers, G.N. Gowda, H. Seeger, and et al. Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer Molecular Oncology 7 2013 297 307
65. C. Wheelock, V. Goss, D. Balgoma, B. Nicholas, J. Brandsma, P. Skipp, and et al. Application of 'omics technologies to biomarker discovery in inflammatory lung diseases. Omics technologies to biomarker discovery The European Respiratory Journal 42 2013 802 825
66. G. Wiesner, T. Slavin, and J. Barnholtz-Sloan Colorectal cancer H. Willard, G. Ginsburg, Genomic and personalized medicine 2009 Elsevier Durham 879 897
67. D. Wishart Computational approaches to metabolomics R. Matthiesen, Bioinformatics methods in clinical research 2010 Humana Press Hatfield, Hertfordshire, UK 283 313
68. J. Xia, N. Psychogios, N. Young, and D. Wishart MetaboAnalyst: A web server for metabolomic data analysis and interpretation Nucleic Acids Research 2009 Web Server issue: W652e60
69. M. Zhang, P. Rosenberg, D. Brown, L. Preiss, B. Konkle, E. Eyster, and et al. Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia Blood 107 2006 892 897
70. Y. Zhen, O. Slanar, K.W. Krausz, C. Chen, J. Slavik, K.L. McPhail, and et al. 3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D metabolic ratio Drug Metabolism and Disposition 34 2006 1563 1574